Infections

233 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Narrower: Adenoviridae Infections 1, Asymptomatic Infections 5, Caliciviridae Infections 3, Chagas Disease 4, Chickenpox 8, Chikungunya Fever 1, Cholera 1, Clostridium Infections 39, Communicable Diseases 18, Coronavirus Infections 10, Cytomegalovirus Infections 4, Dengue 1, Diphtheria 11, Epstein-Barr Virus Infections 1, Escherichia coli Infections 4, Gonorrhea 6, Haemophilus Infections 2, Hemorrhagic Fever, Ebola 6, Herpes Genitalis 3, Herpes Zoster 12, Histoplasmosis 1, Influenza in Birds 1, Latent Tuberculosis 3, Leprosy, Multibacillary 3, Leptospirosis 2, Lyme Disease 1, Malaria 37, Malaria, Falciparum 16, Malaria, Vivax 9, Meningococcal Infections 1, Mycoses 4, Opportunistic Infections 1, Papillomavirus Infections 6, Parasitemia 1, Pneumococcal Infections 5, Rabies 3, Respiratory Syncytial Virus Infections 8, Rotavirus Infections 2, Sepsis 9, Sexually Transmitted Diseases 16, Shock, Septic 5, Staphylococcal Infections 1, Surgical Wound Infection 3, Tetanus 11, Treponemal Infections 1, Trypanosomiasis 6, Trypanosomiasis, African 1, Tuberculosis 13, Tuberculosis, Lymph Node 1, Tuberculosis, Multidrug-Resistant 3, Typhoid Fever 1, Virus Diseases 73, Zika Virus Infection 1

Treatments and conditions

Infections
Treatment and conditionWhere it standsTrials
"Synchronised" arm (intervention) for malariaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
4,4',4''-(4-PROPYL-(1H)-PYRAZOLE-1,3,5-TRIYL)TRISPHENOL for leptospirosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
4CMenB vaccine for gonorrheaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
9vHPV Vaccine for papillomavirus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
abrysvo for respiratory syncytial virus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
abrysvo + Beyfortus for respiratory syncytial virus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Acoziborole for trypanosomiasisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Acoziborole for trypanosomiasis, africanPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)3
Ad26.ZEBOV + MVA-BN-Filo for hemorrhagic fever, ebolaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Adjuvant Dose Arm D for chickenpoxPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Adjuvant Dose Arm D for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Adjuvant Dose Arm F for chickenpoxPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Adjuvant Dose Arm F for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Adjuvant Dose Arm H for chickenpoxPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Adjuvant Dose Arm H for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Adjuvant Dose Arm J for chickenpoxPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Adjuvant Dose Arm J for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Adjuvant Dose Arm L for chickenpoxPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Adjuvant Dose Arm L for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Antigen High Dose Arm A for chickenpoxPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Antigen High Dose Arm A for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Antigen Low Dose Arm B for chickenpoxPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amezosvatein Antigen Low Dose Arm B for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Amoxicillin for treponemal infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ansuvimab for hemorrhagic fever, ebolaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Artemether + Lumefantrine for malaria, vivaxPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Artemether + Lumefantrine + TAFENOQUINE for malaria, vivaxPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
artemether-lumefantrine for malaria, falciparumTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
artemether-lumefantrine + Mosquirixs for malaria, falciparumTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Artesunate for cytomegalovirus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Atovaquone-Proguanil for asymptomatic infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Atovaquone-Proguanil for malaria, falciparumPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Awake timed prone and repositioning for coronavirus infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
AZD7760 for sepsisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
AZD7760 for staphylococcal infectionsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bacillus calmette-guerin live antigen, unspecified substrain for tuberculosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bedaquiline for tuberculosis, multidrug-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Benznidazole for chagas diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
Beyfortus for respiratory syncytial virus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bezlotoxumab for clostridium infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Biospecimen Collection + Nasal Swab + Survey Administration + REMDESIVIR for respiratory syncytial virus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Blmz for tuberculosis, multidrug-resistantTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Blood and adrenaline for choleraPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Blood and adrenaline for shock, septicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
BPaLMZ Regimen for latent tuberculosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cabamiquine for malaria, falciparumPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Chlorhexidine for infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Circulating Tumor DNA test (ctDNA test) + Dose de-escalation to contralateral neck. + Dose de-escalation to gross disease + Dose de-escalation to gross disease to contralateral neck for papillomavirus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
coadministration for rabiesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Coartem® Baby for malariaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
COVID-19 vaccine for rabiesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
CVI-VZV-001 for chickenpoxPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
CVI-VZV-001 for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine) for diphtheriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine) for haemophilus infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine) for tetanusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DAPTACEL®: DTaP for diphtheriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DAPTACEL®: DTaP for tetanusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DAPTACEL®. (DTaP), IPOL®., and ActHIB®. for diphtheriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DAPTACEL®. (DTaP), IPOL®., and ActHIB®. for tetanusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
dexmedetomidine nasal spray group + long duration high voltage pulse RF therapy group for herpes zosterPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dihydroartemisinin + Piperaquine tetraphosphate for malaria, vivaxPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dihydroartemisinin + Piperaquine tetraphosphate + TAFENOQUINE for malaria, vivaxPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dihydroartemisinin-Piperaquine (DP) for malariaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine, BK1301) for diphtheriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine, BK1301) for tetanusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed for diphtheriaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed for tetanusPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dolutegravir + Isoniazid + RIFAPENTINE for latent tuberculosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
DTaP (Diphtheria & Tetanus Toxoids & Acellular Pertussis Adsorbed) for diphtheriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DTaP (Diphtheria & Tetanus Toxoids & Acellular Pertussis Adsorbed) for tetanusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DTaP-IPV and ActHIB® for diphtheriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DTaP-IPV and ActHIB® for tetanusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DTaP-IPV combined vaccine for diphtheriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DTaP-IPV combined vaccine for tetanusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Efineptakin alfa for opportunistic infectionsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
EG-MCV4 for meningococcal infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
EGCG and Quinine Sulfate Vaginal Suppository for papillomavirus infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ervebo® booster for hemorrhagic fever, ebolaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Etofenprox-treated lesu for malaria, falciparumTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Factory-treated lesu for malaria, falciparumTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Faecal bacteriotherapy (FBT) for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Microbial Transplantation for clostridium infectionsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fecal microbiota for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)5
Fecal Microbiota Transplant for clostridium infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Fecal Microbiota Transplant (FMT) for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fecal microbiota transplant (Promicrobioma) for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Microbiota Transplantation (FMT) for clostridium infectionsTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Microbiota Transplantation (FMT) + ISOTONIC SODIUM CHLORIDE SOLUTION for clostridium infectionsTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Fecal microbiota transplantion (FMT) for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Transplant for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Virome Transplantation for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fidaxomicin for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Flucytosine (5FC) for mycosesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Flucytosine (5FC) + Liposomal Amphotericin B (LAmB) for mycosesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fluvoxamine for coronavirus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fmt for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)3
FMT (Fecal Microbiota Transplantation) for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
FMT-c Lactobacillus for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Formulation B for pneumococcal infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Formulation C for pneumococcal infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Formulation D for pneumococcal infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fosravuconazole + benznidazole for chagas diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fresh FMT for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Frozen-and-Thawed FMT for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Gepotidacin for gonorrheaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
GSK malaria vaccine 257049 Vaccine for malariaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Healthy donor stool for clostridium infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Hemoperfusion for leptospirosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
High dose Recombinant Trivalent Subunit Rotavirus Vaccine for rotavirus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
High-dose experimental vaccine for herpes zosterPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Hydroxychloroquine for coronavirus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
hydroxychloroquine + azithromycin for coronavirus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
IFN-γ positive selected T-cells for adenoviridae infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
IFN-γ positive selected T-cells for cytomegalovirus infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Immulina for virus diseasesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Inmazeb for hemorrhagic fever, ebolaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Isoniazid + RIFAPENTINE for latent tuberculosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)2
Ivermectin for asymptomatic infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ivermectin for communicable diseasesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ivermectin for malariaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Landiolol for shock, septicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lb-dtk-mv for cytomegalovirus infectionsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lb-dtk-mv for epstein-barr virus infectionsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
LBP-EC01 for escherichia coli infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
LBP-EC01 0.01x IV Dose for escherichia coli infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
LBP-EC01 0.1 x IV dose for escherichia coli infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
LBP-EC01 IV Infusion Dose for escherichia coli infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Liposomal Amphotericin B (LAmB) for mycosesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Low Dose FMT Capsule DE for clostridium infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Low-dose experimental vaccine for herpes zosterPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
M5717 200 mg + PYRONARIDINE for asymptomatic infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
M5717 200 mg + PYRONARIDINE for malaria, falciparumPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
M5717 330 mg + PYRONARIDINE for malaria, falciparumPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
M5717 500 mg + M5717 660 mg + PYRONARIDINE for malaria, falciparumPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
M5717 60 mg + PYRONARIDINE for asymptomatic infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
M5717 60 mg + PYRONARIDINE for malaria, falciparumPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
M5717 660mg + PYRONARIDINE for asymptomatic infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
M5717 660mg + PYRONARIDINE for malaria, falciparumPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine for tuberculosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Malaria Vaccine 257049 for malariaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Malaria Vaccine 257049 + Polio Sabin Oral Polio Vaccine (GSK) + TritanrixHepB/Hib for malariaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Matrix-M with RH5.2 VLP and/or R21 for malaria, falciparumPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
MBK-01 for clostridium infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Meningococcal Group B Vaccine for gonorrheaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Metformin for tuberculosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Methylenblue for malariaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
METRONIDAZOLE + Vancomycin + Loperamide + FECAL MICROBIOTA for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine for rotavirus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Midodrine for sepsisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mosquirixs for malaria, falciparumTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Moxifloxacin + rifapentine for tuberculosis, lymph nodePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
mRNA-1018-H5 for influenza in birdsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mtbvac for tuberculosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
N-Acetylcysteine (NAC) Treatment for tuberculosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Nifurtimox for chagas diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Nirsevimab for respiratory syncytial virus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
Oxygen-ozone therapy, probiotic supplementation and Standard of care + SivoMixx (200 billion) for coronavirus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
pBI-11 (1 dose) + Placebo (2 doses) for papillomavirus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
pBI-11 (3 doses) for papillomavirus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
PEDIACEL® and Prevenar® for diphtheriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
PEDIACEL® and Prevenar® for haemophilus infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
PEDIACEL® and Prevenar® for pneumococcal infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
PEDIACEL® and Prevenar® for tetanusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Penn Microbiome Therapy - 001 for clostridium infectionsTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Penn Microbiome Therapy - 001 + Penn Microbiome Therapy - 002 + Penn Microbiome Therapy - 003 for clostridium infectionsTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Penn Microbiome Therapy - 002 + Penn Microbiome Therapy - 003 for clostridium infectionsTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Pentacel®: DTaP-IPV/Hib combined for diphtheriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Pentacel®: DTaP-IPV/Hib combined for tetanusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Permethrin-treated lesu for malariaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Permethrin-treated lesu for malaria, falciparumTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
PG4 for pneumococcal infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for herpes genitalisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for tuberculosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Polio Sabin Oral Polio Vaccine (GSK) + TritanrixHepB/Hib for malariaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Posaconazole for chagas diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Povidone-iodine for surgical wound infectionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Primaquine for malaria, vivaxPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Prone Position for coronavirus infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
prone positioning for coronavirus infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Prone Positioning (PP) for coronavirus infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Pvs230D1-EPA/Matrix-M for malaria, vivaxTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Pvs230D1-EPA/Matrix-M for parasitemiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Quabodepistat for tuberculosis, multidrug-resistantPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
R21 in Matrix- M adjuvant vaccine for malaria, falciparumPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
R21/Matrix-M - single vial formulation for malariaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
R21/Matrix-M - two vial formulation for malariaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
rabies vaccine for rabiesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
RBX2660 for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
RBX2660 for communicable diseasesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
RBX2660 (microbiota suspension) for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Recombinant varicella zoster virus glycoprotein e antigen for herpes zosterPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
RECOMBINANT ZAIRE EBOLAVIRUS KIKWIT-95 ENVELOPE GLYCOPROTEIN MODIFIED VESICULAR STOMATITIS VIRUS for hemorrhagic fever, ebolaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
RSVPreF3 OA investigational vaccine for respiratory syncytial virus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
S-337395 for respiratory syncytial virus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Single high dose of liposomal amphotericin B for histoplasmosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Soaked lesu for malaria, falciparumTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Standardized kudzu for sexually transmitted diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Sucrose for surgical wound infectionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tafenoquine for malaria, vivaxPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
Tafenoquine + chloroquine for malaria, vivaxPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tafenoquine succinate for malaria, vivaxPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tdap (Tetanus Toxoid Reduced Diphtheria Toxoid/Acellular Pertussis) for diphtheriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tdap (Tetanus Toxoid Reduced Diphtheria Toxoid/Acellular Pertussis) for tetanusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Telacebec + Rifampicine for leprosy, multibacillaryTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Telacebec 300 mg for leprosy, multibacillaryTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Telacebec 600 mg for leprosy, multibacillaryTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Temocillin (NEGABAN®) 2 g intramuscular single dose with lidocaine (3ml) for gonorrheaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Temocillin (NEGABAN®) 2 g intravenous with lidocaine (3ml) for gonorrheaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tetanus-Diphtheria booster for papillomavirus infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Titrated weaning of vasopressin. for shock, septicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Topical ceftazidime and vancomycin for surgical wound infectionPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tradipitant for coronavirus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tranexamic acid for sepsisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
UB-621 high-dose for herpes genitalisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
UB-621 low-dose for herpes genitalisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Valganciclovir for cytomegalovirus infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Vancomycin for clostridium infectionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Vasopressin for shock, septicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Venous Excess Ultrasound (VEXUS)-Guided Management for shock, septicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Vi-Typhoid Conjugate Vaccine (Vi-TCV) for typhoid feverPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Viral Specific T-cells (VSTs) for virus diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
VLA15 for lyme diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
VXA-G1.1-NN for caliciviridae infectionsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
VXA-G1.1-NN + VXA-G2.4-NS for caliciviridae infectionsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
VXA-G2.4-NS for caliciviridae infectionsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Wharton's jelly derived Mesenchymal stem cells. for coronavirus infectionsTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Wolbachia-infected Aedes aegypti for chikungunya feverTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Wolbachia-infected Aedes aegypti for dengueTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Wolbachia-infected Aedes aegypti for zika virus infectionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Zabdeno® booster for hemorrhagic fever, ebolaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zelicapavir for respiratory syncytial virus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zoliflodacin for gonorrheaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.